Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab

被引：0
|
作者：
Cioppa, Vittoria [1 ]
Lazzeri, Laura [1 ]
Carraro, Andrea [1 ]
De Piano, Ernesto [1 ]
Falcinelli, Francesca [1 ]
Galluzzo, Marco [2 ]
Pallotta, Sabatino [3 ]
De Pita, Ornella [3 ]
Russo, Filomena [3 ]
机构：
[1] Univ Siena, S Maria Scotte Hosp, Dept Med Surg & Neurol Sci, Dermatol Sect, Siena, Italy
[2] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy
[3] Dermatol Res Hosp, IDI IRCCS, Rome, Italy
来源：
DERMATITIS | 2024年 / 35卷
关键词：
D O I：
10.1089/derm.2023.0052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [32] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [33] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [34] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Muraro, Antonella
    Boguniewicz, Mark
    Chen, Zhen
    Zahn, Joseph
    Marco, Ainara Rodriguez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01)
  • [35] Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States
    Franklin, Jessica M.
    Marcus, Andrea F.
    Sultan, Ihtisham
    Howell, Ashley
    Sinnott, Sarah-Jo
    Green, Jeannette
    Ezzy, Stephen M.
    Gately, Robert
    Sobel, Rachel E. E.
    Wang, Florence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 77 - 78
  • [36] Patient wellbeing and perception of treatment effect with long-term dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis
    Simpson, E. L.
    Beissert, S.
    Beck, L. A.
    Zhang, H.
    Aamodt, K.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E139 - E139
  • [37] Long-term dupilumab treatment is not associated with an increased overall risk of infections in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Thaci, Diamant
    de Bruin-Weller, Marjolein
    Deleuran, Mette
    Kataoka, Yoko
    Friedman, Adam J.
    Khokhar, Faisal A.
    Coleman, Anna
    Gherardi, Guy
    Chen, Zhen
    Avetisova, Elena
    Zhang, Annie
    Nguyen, Tien, V
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 71 - 72
  • [38] Efficacy of dupilumab in moderate and severe atopic dermatitis
    Weidinger, Stephan
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Schmitt, Jochen
    Leshem, Yael A.
    Katoh, Norito
    Chen, Zhen
    Zhang, Haixin
    Shumel, Brad
    Bansal, Ashish
    Chao, Jingdong
    Lu, Yufang
    Rossi, Ana B.
    Abramova, Alvina
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 247 - 260
  • [39] Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 64 - 66
  • [40] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
12345